NRBO News and Press, NeuroBo Pharmaceuticals Inc. From 09/15/22

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: shutterstock.com/Anastasia Zagoruyko HeartBeam (NASDAQ: BEAT ) stock is rocketing higher on Thursday as investors react to news of a new heart monitor patent . This new patent covers a 12-lead electro...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Bukhta Yurii / Shutterstock.com NeuroBo (NASDAQ: NRBO ) stock is rising higher on Thursday after the clinical-stage biotechnology company announced a new strategic partnership with Dong-A ST . Neuro...

Boston-based NeuroBo Pharmaceuticals' ( NASDAQ: NRBO ) stock rose ~35% on Sept. 15 after it signed an agreement to license its shareholder Dong-A's two cardiometabolic assets DA-1241 and DA-1726. DA-1241 is being developed to treat nonalcoholic steatohepatitis (NASH)...

NeuroBo Pharmaceuticals, Inc. and Dong-A ST Co. Ltd. Announce Strategic Collaboration to License and Develop Portfolio of Dong-A's Cardio-Metabolic Therapies PR Newswire Exclusive License Agreement to Develop and Commercialize Phase II Clinical Stage New Chemical Entit...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: f11photo/Shutterstock.com It’s time for another dive into the biggest pre-market stock movers as we see why shares are moving Thursday morning! Moving stocks this morning is clinical trial data, propo...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Eric Urquhart/Shutterstock.com We’re starting off Wednesday with an overview of the biggest pre-market stock movers and the news moving those shares! That includes earnings reports, reverse stock spli...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Andrus Ciprian / Shutterstock.com NeuroBo Pharmaceuticals  (NASDAQ: NRBO ) stock is rocketing higher on Tuesday after the company underwent a reverse stock split  this morning. NRBO stock we...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today’s price action in  NeuroBo  (NASDAQ: NRBO ) is quite remarkable, to say the least. While many stocks in the market are up today, few have seen triple-digit increases like this clinical-stage biote...

NeuroBo Pharmaceuticals ( NASDAQ: NRBO ) shares are surging 56% on announcing a 1-for-30 reverse split of its common stock, par value $0.001. The trading on a split adjusted basis will commence on Nasdaq from September 13, 2022. The number of authorized shares of t...

NeuroBo Pharmaceuticals Announces Reverse Stock Split PR Newswire BOSTON , Sept. 12, 2022 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO) ("NeuroBo" or the "Company"), a clinical-stage biotechnology company, announced today a 1-for-30 reverse...